This is the last thing you want because that makes the prostate and cancer grow.

With our new prostate cancer initiative, we are once again taking a forward-looking approach to our underwriting because we expect that the significant progress made against this disease will continue. We hope to make a difference in people's lives with our expertise and our actions. Early screening and detection are critical for beating prostate cancer. We hope every man in America who is age 50 and older will undergo regular screenings and remain vigilant against this disease.

While hormone resistance can likely be acquired in multiple ways, it appears we may have uncovered a general contributor to hormone resistance in prostate cancer.

Otherwise, the team of international experts found no evidence for any increases in the incidence of leukemia and cancer among affected residents.

Dedicated researchers seek better treatments and cures for diabetes, kidney disease, Alzheimer's and every form of cancer. But these scientists face an array of disincentives. We can do better.

Even if we could reduce deaths from one disease, like ovarian cancer, the return on investment would be priceless.